Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EW0198 | — |
shortness of breath; reduced energy; This is a spontaneous report received from a Consumer or other non HCP. A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jul2021 as dose 1, single (Lot number: EW0198) at the age of 56 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: May2017; HYDROCHLOROTHIAZIDE, start date: Jan2020; LOSARTAN, start date: Sep2020. Past drug history included: Lisinopril, reaction(s): "allergy". The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath"; ASTHENIA (non-serious), outcome "unknown", described as "reduced energy". Additional information: Not long after taking the vaccines, the patient had shortness of breath and reduced energy.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500084622 Same patient/drug; different dose/events;
Medical History/Concurrent Conditions: Blood pressure high; Hypothyroidism
LEVOTHYROXINE; HYDROCHLOROTHIAZIDE; LOSARTAN